LRIG1 has not been associated with improved survival when expressed in the perinulear region, while the protein expression of LRIG2 and LRIG3 in the perinuclear area of astrocytoma cells has been found to correlate with improved patient survival (17). This evidence concerns the gene LRIG2 and astrocytoma (excluding glioblastoma).